Hypoglycemia associated with maprotiline in a patient with type 1 diabetes.
Isotani
H
H
Kameoka
K
K
D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D001786:Blood Glucose / Q000378:metabolism; D002096:C-Peptide / Q000097:blood; D003866:Depressive Disorder / Q000150:complications / Q000188:drug therapy*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D005260:Female; D005934:Glucagon; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced*; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D008376:Maprotiline / Q000009:adverse effects*
D018687:Antidepressive Agents, Second-Generation; D001786:Blood Glucose; D002096:C-Peptide; D007004:Hypoglycemic Agents; D007328:Insulin; D008376:Maprotiline; D005934:Glucagon